Research uncovers a new alkyne warhead for targeting hTG2, indicating potential for therapeutic applications in diseases like cancer.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mader et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: